Results 101 to 110 of about 26,703 (203)
Journal of General and Family Medicine, Volume 27, Issue 3, May 2026.ABSTRACT A 71‐year‐old woman presented with acute muscle weakness and paresthesia in her left lower limb with the preceding back pain and impaired deep sensation. Although initial brain and spinal MRI were normal, follow‐up spinal MRI confirmed the left‐sided posterior lesion at T10 to T12 vertebral level, leading to the diagnosis of posterior spinal ...
Munenori Iwamoto +2 more
wiley +1 more source
Evaluación del uso de rituximab en la neuromielitis óptica
Neurología, 2015 Resumen: Introducción: La neuromielitis óptica es un trastorno autoinmune, inflamatorio y desmielinizante del sistema nervioso central que afecta a la médula espinal y al nervio óptico, de carácter recurrente.
M.J. Fernández-Megía +5 more
doaj +1 more source
Hypersensitivity Responses in the Central Nervous System [PDF]
, 2015 Immune-mediated tissue damage or hypersensitivity can be mediated by autospecific IgG antibodies. Pathology results from activation of complement, and antibody-dependent cellular cytotoxicity (ADCC), mediated by inflammatory effector leukocytes include ...
Carsten Tue Berg +5 more
core +4 more sources
Clinical and Experimental Neuroimmunology, Volume 17, Issue 2, May 2026.ABSTRACT Background Some patients with myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) experience multiple relapses and poor prognoses; however, the factors associated with these outcomes are unclear. This study aimed to identify factors associated with relapse and neurological prognosis in patients with MOGAD.
Masashi Nakamura +4 more
wiley +1 more source
Spinal anesthesia for cesarean delivery in a woman with neuromyelitis optica. [PDF]
, 2014 Neuromyelitis optica (NMO), or Devic's disease, is an idiopathic severe demyelinating disease that preferentially affects the optic nerve and spinal cord. Neuraxial anesthesia in women with multiple sclerosis is widely accepted, but reports of the use of
Ciliberto, C +4 more
core +1 more source
Clinical and Experimental Neuroimmunology, Volume 17, Issue 2, May 2026.ABSTRACT Background Satralizumab is used for the treatment of neuromyelitis optica spectrum disorder (NMOSD). However, there are currently no standardized guidelines regarding the method or speed of steroid tapering after its introduction. In 2023, we proposed a method to commence tapering prednisolone at a rate of 1 mg every 4 weeks, starting 8 weeks ...
Kiyotaka Nakamagoe +4 more
wiley +1 more source
Journal of Neurochemistry, Volume 170, Issue 5, May 2026.Neuroinflammatory diseases of the CNS are difficult to diagnose, and current CSF biomarkers lack sensitivity across conditions. Soluble CD27 (sCD27), a marker of adaptive immune activation, has emerged as a promising candidate, but its clinical utility remains uncertain.
Nadia Damholt Savino +5 more
wiley +1 more source
Induced CNS expression of CXCL1 augments neurologic disease in a murine model of multiple sclerosis via enhanced neutrophil recruitment. [PDF]
, 2018 Increasing evidence points to an important role for neutrophils in participating in the pathogenesis of the human demyelinating disease MS and the animal model EAE.
Doty, Daniel J +7 more
core +1 more source
Case Reports in Clinical Practice, 2018 Systemic lupus erythematosus is an autoimmune disease. Neuromyelitis optica (Devic’s disease) is an inflammatory disorder belonging to the central nervous system.
Asal Azami, Mohammadhassan Jokar
doaj